Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy.
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5. doi: 10.1016/j.bmcl.2010.04.114. Epub 2010 Apr 28.
We investigated the inhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms I-XV with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylsulfamide and other simple or sugar sulfamides, a class of less investigated CA inhibitors (CAIs). The crystal structure of the adduct of hCA II with the boron-substituted sulfamide shows the organic scaffold of this compound bound in the hydrophilic half of the active site where it makes a large number of van der Waals contacts with Ile91, Gln92, Val121, Phe131, Leu198, and Thr200. The data here reported provide further insights into sulfamide binding mechanism confirming that this zinc-binding group could be usefully exploited for obtaining new potent and selective CAIs.
我们研究了 4-(4,4,5,5-四甲基-1,3,2-二氧杂戊硼烷-2-基)苯磺酰胺和其他简单或糖磺酰胺对碳酸酐酶(CA,EC 4.2.1.1)同工酶 I-XV 的抑制作用,这些都是研究较少的碳酸酐酶抑制剂(CAIs)的一类。与硼取代磺酰胺结合的 hCA II 的晶体结构显示,该化合物的有机支架结合在活性部位的亲水半部分,与 Ile91、Gln92、Val121、Phe131、Leu198 和 Thr200 形成大量范德华接触。这里报道的数据进一步深入了解了磺酰胺结合机制,证实了这种锌结合基团可用于获得新的有效且选择性的 CAIs。